VA‐Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations
Pediatric Blood & Cancer · 2026
DOI: 10.1002/pbc.32149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Bryan A Sisk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Lymphatic Abnormalities, Communication, Electronic Health Records, Parents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Lymphatic Malformation Institute.
Abstract (Originalsprache)
Background
Complex lymphatic anomalies (CLAs) and lymphatic malformations (LMs) are rare diseases that cause lifelong complications. High‐quality communication is essential for providing safe and effective care, but many families report insufficient communication and unreliable information. We aimed to develop and pilot a communication tool embedded within an electronic health record system.
Methods
We developed separate versions of VA‐Comm for CLAs and LMs through participatory design workshops, including three workshops with parents and adult patients ( n = 9) and two workshops with expert physicians ( n = 10). We performed usability testing ( n = 5) prior to finalizing the tool. We then piloted VA‐Comm with 22 participants (18 parents and 4 adult patients). We administered surveys with communication and care coordination measures pre‐ and post‐intervention, as well as performing post‐intervention interviews.
Results
Participants completed 70% of tasks on average, and 14/22 participants completed 70% of tasks. Pre‐/Post surveys demonstrated a statistical improvement in parental anxiety (mean decrease by 4.6 T‐score points, p = 0.01). No other survey score differences were statistically significant, but nearly all responses directionally improved. VA‐Comm was rated as highly acceptable (parent mean = 17.5/20, SD = 1.8; patient mean = 18.3/20, SD = 2.1) and appropriate (parent mean = 17.3/20, SD = 1.8; patient mean = 18.0/20, SD = 2.0). Post‐intervention interviews with 18 participants provided feedback on VA‐Comm components and identified 3 factors influencing usage: usefulness, ease of use, and personal characteristics and circumstances.
Conclusion
Implementing VA‐Comm was feasible, and participants held positive views on the usefulness and ease of use. VA‐Comm can serve as a framework for improving communication in other serious illnesses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Washington University School of Medicine, St. Louis, Missouri, USA.
- Washington University School of Public Health, St. Louis, Missouri, USA.
- Children's Hospital of Colorado, Aurora, Colorado, USA.
- Oregon Health and Science University, Doernbecher Children's Hospital, Portland, Oregon, USA.
- University of North Carolina, Chapel Hill, North Carolina, USA.
ORCID-Profile: Bryan A Sisk, Taizo A Nakano, Anna M Kerr
Förderung
- Lymphatic Malformation Institute
Zitieren
APA
Sisk, B. A., Kepper, M. M., Bereitschaft, C., Milam, S., Chen, S., Nakano, T. A., Wu, M. D., Borst, A. J., & Kerr, A. M. (2026). VA‐Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32149
Vancouver
Sisk BA, Kepper MM, Bereitschaft C, Milam S, Chen S, Nakano TA, et al. VA‐Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.32149
BibTeX
@article{Sisk2026,
author = {Sisk, Bryan A and Kepper, Maura M and Bereitschaft, Christine and Milam, Stephanie and Chen, Stephanie and Nakano, Taizo A and Wu, Melinda D and Borst, Alexandra J and Kerr, Anna M},
title = {VA‐Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/pbc.32149}
}
EUVIMED